Scott Houlton became a member of the Great Point Partners CEO Advisory Board in 2018 after the sale of Clinical Supplies Management (“CSM”), a GPP II portfolio company.
Mr. Houlton joined CSM as CEO in 2016, completed two European tuck-ins (Belgium and Germany), tripled revenues and 23 months later in September 2018, led the sale of the business to Clinigen. Previously, he was President at Catalent Pharma Solutions where, over a five-year period, he increased revenue from $140 million to $450 million and EBITDA from $24 million to $100 million. Prior to Catalent, he was the Chief Operating Officer at Aptuit.
Mr. Houlton graduated cum laude with a bachelor’s degree in finance and in international business from Ohio State University.
- Clinical Supplies Management – clinical trials supplies management
- Catalent Pharma Solutions – drug and biologic development service